Prevalence, kinetic changes and possible reasons of elevated cardiac troponin T in patients with AV nodal re-entrant tachycardia.

M Schueler, M Vafaie, R Becker, M Biener, D Thomas, M Mueller, E Giannitsis, Hugo A Katus
{"title":"Prevalence, kinetic changes and possible reasons of elevated cardiac troponin T in patients with AV nodal re-entrant tachycardia.","authors":"M Schueler,&nbsp;M Vafaie,&nbsp;R Becker,&nbsp;M Biener,&nbsp;D Thomas,&nbsp;M Mueller,&nbsp;E Giannitsis,&nbsp;Hugo A Katus","doi":"10.3109/17482941.2012.741246","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Elevated cardiac troponin (cTn) has been reported to occur with AVNRT. Little is known about prevalence, kinetic changes, and possible reasons of increased cTn.</p><p><strong>Methods: </strong>We evaluated 139 consecutive patients presenting with AVNRT to the emergency department between 2006 and 2010. Cardiac troponin T (cTnT) was measured serially at baseline, after three and six hours. Patients were evaluated for the presence of structural heart disease or CAD. Troponin was defined as elevated if a value exceeded the lower limit of detection (10 ng/l) using the fourth generation cTnT, or if the value > 99 th percentile (14 ng/l) using the new highly sensitive cTn assay.</p><p><strong>Results: </strong>A cTnT > LLD (n = 29) or > 99 th percentile (n = 16) was found in 45 patients (32.4%) within the initial six hours after hospitalization. All patients were symptomatic with palpitations, chest discomfort or dyspnea. A complete cardiac evaluation was carried out, including coronary angiography in 32 patients demonstrating an underlying structural heart disease or CAD in 18 cases (56%). Significant CAD was detected in 16 cases. 8 cases required PCI during hospitalization. Elevated cTnT was seen in patients with and without structural heart disease.</p><p><strong>Conclusions: </strong>AVNRT is a possible reason for elevated cTnT, even in the absence of relevant structural heart disease or CAD.</p>","PeriodicalId":87385,"journal":{"name":"Acute cardiac care","volume":"14 4","pages":"131-7"},"PeriodicalIF":0.0000,"publicationDate":"2012-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/17482941.2012.741246","citationCount":"14","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acute cardiac care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3109/17482941.2012.741246","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 14

Abstract

Background: Elevated cardiac troponin (cTn) has been reported to occur with AVNRT. Little is known about prevalence, kinetic changes, and possible reasons of increased cTn.

Methods: We evaluated 139 consecutive patients presenting with AVNRT to the emergency department between 2006 and 2010. Cardiac troponin T (cTnT) was measured serially at baseline, after three and six hours. Patients were evaluated for the presence of structural heart disease or CAD. Troponin was defined as elevated if a value exceeded the lower limit of detection (10 ng/l) using the fourth generation cTnT, or if the value > 99 th percentile (14 ng/l) using the new highly sensitive cTn assay.

Results: A cTnT > LLD (n = 29) or > 99 th percentile (n = 16) was found in 45 patients (32.4%) within the initial six hours after hospitalization. All patients were symptomatic with palpitations, chest discomfort or dyspnea. A complete cardiac evaluation was carried out, including coronary angiography in 32 patients demonstrating an underlying structural heart disease or CAD in 18 cases (56%). Significant CAD was detected in 16 cases. 8 cases required PCI during hospitalization. Elevated cTnT was seen in patients with and without structural heart disease.

Conclusions: AVNRT is a possible reason for elevated cTnT, even in the absence of relevant structural heart disease or CAD.

房室结型再入性心动过速患者肌钙蛋白T升高的患病率、动力学变化及可能的原因。
背景:有报道称AVNRT患者心肌肌钙蛋白(cTn)升高。目前对cTn的患病率、动态变化和可能的原因知之甚少。方法:我们评估了2006年至2010年间139例连续出现AVNRT的急诊科患者。心脏肌钙蛋白T (cTnT)在基线、3小时和6小时后连续测量。评估患者是否存在结构性心脏病或CAD。如果使用第四代cTnT的值超过检测下限(10 ng/l),或者如果使用新的高灵敏度cTn检测的值> 99百分位数(14 ng/l),则肌钙蛋白被定义为升高。结果:45例(32.4%)患者在住院后最初6小时内出现cTnT > LLD (n = 29)或> 99百分位(n = 16)。所有患者均有心悸、胸部不适或呼吸困难等症状。进行了完整的心脏评估,包括32例患者的冠状动脉造影,其中18例(56%)显示潜在的结构性心脏病或CAD。16例检测到明显的CAD。住院期间行PCI治疗8例。无论有无结构性心脏病,cTnT水平均升高。结论:AVNRT是cTnT升高的一个可能原因,即使在没有相关的结构性心脏病或CAD的情况下。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信